论文部分内容阅读
目的分析长期吸入普米克都保气雾剂和间断吸入沙丁胺醇气雾剂治疗哮喘的临床疗效。方法选择我院自2015年7月至2016年7月期间收治的哮喘患者64例,依据患者来院先后顺序均分两组,每组患者例数各32例。予以长期吸入普米克都保气雾剂治疗的患者作为实验组,予以间断吸入沙丁胺醇气雾剂治疗的患者作为参照组,最后对两组哮喘患者的治疗效果进行统计和分析。结果两组患者治疗前,比对哮喘控制效果和最大呼吸气流量,未形成统计学意义;经不同方法治疗后,比对哮喘控制效果和最大呼吸气流量,统计学意义形成。与此同时两组患者治疗后均未出现不良反应。结论在哮喘治疗中,长期吸入普米克都保气雾剂同间断吸入沙丁胺醇气雾剂更具优势,但是两种方法治疗效果相当,因此可以结合患者的实际情况情况合理选择。
OBJECTIVE: To analyze the clinical efficacy of long-term inhalation of Pulmicort Pneumatic aerosol and intermittent inhalation of albuterol aerosol in the treatment of asthma. Methods Sixty-four patients with asthma admitted to our hospital from July 2015 to July 2016 were selected and divided into two groups according to their order of visit to hospital: 32 cases in each group. Long-term inhalation of Pulmicort Pneumoconiosis patients as experimental group, intermittent inhalation of salbutamol aerosol treatment of patients as a reference group, and finally the two groups of patients with asthma treatment effect statistics and analysis. Results Before treatment, the two groups had no significant difference in the control effect and the maximum respiration gas flow rate. After treatment by different methods, the control effect and the maximum respiration gas flow rate were statistically significant. At the same time, no adverse reactions occurred in both groups after treatment. Conclusions In the treatment of asthma, long-term inhalation of Pimecchurow’s aerosol inhalation is more advantageous than intermittent inhalation of albuterol aerosol. However, the two methods have the same effect and can be reasonably selected according to the actual situation of patients.